NCT01615809View on ClinicalTrials.gov

Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Invasive Pulmonary AspergillosisLymphoblastic LeukaemiaMyeloblastic LeukaemiaLymphoblastic LeukemiaMyeloblastic Leukemia
Interventions
DRUG

AMPHOTERICIN B

The study drug will be administered by inhalation, to hospitalised patients or outpatients in the day hospital.

Trial Locations (1)

08950

Hospital Sant Joan de Déu, Esplugues de Llobregat

All Listed Sponsors
collaborator

Ministry of Health, Spain

OTHER_GOV

lead

Fundació Sant Joan de Déu

OTHER

NCT01615809 - Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia | Biotech Hunter | Biotech Hunter